Biopool International receives FDA 510k approval to market blood-coagulation test kit.
Business Wire › September 06, 1996
Linked as:
Extract
Biopool International receives FDA 510k approval to market blood-coagulation test kit.
VENTURA, Calif.--(BUSINESS WIRE)--Sept. 6, 1996--Biopool International Inc. (NASDAQ:BIPL) Friday announced that it has received U.S. Food and Dr...
See the full content of this document
Sponsored links
